Celemics, Inc.

  • Home
  • Celemics, Inc.
Call Directions Website Contact the business

Celemics, Inc. CELEMICS innovates NGS-based material with novel sequencing technology to disrupt the paradigm of me

𝗪𝗵𝗲𝗻 𝗱𝗼𝗲𝘀 𝗮 𝗧𝗮𝗿𝗴𝗲𝘁 𝗘𝗻𝗿𝗶𝗰𝗵𝗺𝗲𝗻𝘁 𝗽𝗮𝗻𝗲𝗹 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗻𝗲𝗲𝗱 𝗟𝗼𝗻𝗴-𝗿𝗲𝗮𝗱 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴? 🔗 Read the full blog: https://lnkd.in/gAbcKHhVSh...
15/09/2026

𝗪𝗵𝗲𝗻 𝗱𝗼𝗲𝘀 𝗮 𝗧𝗮𝗿𝗴𝗲𝘁 𝗘𝗻𝗿𝗶𝗰𝗵𝗺𝗲𝗻𝘁 𝗽𝗮𝗻𝗲𝗹 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗻𝗲𝗲𝗱 𝗟𝗼𝗻𝗴-𝗿𝗲𝗮𝗱 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴? 🔗 Read the full blog: https://lnkd.in/gAbcKHhV

Short-read platforms have carried most Target Enrichment workflows to date, and for good reason fragmented DNA hybridizes efficiently with capture probes, and high depth of coverage is economical to reach. But pseudogenes, homologous regions, and large structural variants remain difficult to resolve at 150–300 bp.

Long-read Target Enrichment addresses those regions directly, at the cost of more demanding sample preparation: HMW DNA integrity has to be maintained through handling, bead wash, and elution while hybridization still needs to work.

In our latest blog, Celemics walks through how read length, hybridization behavior, sample preparation, and analysis targets differ between the two platforms and how to decide which one (or which combination) fits a given target region.

26/08/2026

𝗖𝗮𝗻 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝗡𝗚𝗦 𝗹𝗶𝗯𝗿𝗮𝗿𝘆 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗱𝗲𝗹𝗶𝘃𝗲𝗿 𝗰𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗹𝗲 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗮𝗰𝗿𝗼𝘀𝘀 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀?

Celemics evaluated libraries prepared with its Library Preparation Kit and Custom Capture Panels on both Element Biosciences AVITI and Illumina NextSeq 500 using the same analysis pipeline.

The results showed comparable sequencing performance between the two platforms across both panels tested.

For laboratories considering multiple sequencing platforms, this means the same Celemics library preparation workflow can be applied to both AVITI and Illumina without maintaining separate preparation workflows.

Explore the full comparison and detailed results in our latest blog and Application Note.

19/08/2026

𝗝𝗼𝗶𝗻 𝗖𝗲𝗹𝗲𝗺𝗶𝗰𝘀 𝗮𝘁 𝗘𝗦𝗖𝗩 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗣𝗼𝗿𝘁𝗼!

Discover our NGS solutions for pathogen detection and genomic surveillance, designed to support high-sensitivity detection even in low viral load and complex clinical samples.

Explore our target enrichment technology, ready-to-use and customizable pathogen panels, and integrated workflows for detecting diverse pathogens and emerging variants.

📅 16–19 September 2026
📍 Porto, Portugal
📌 Booth

We look forward to seeing you in Porto!

11/08/2026

𝗪𝗵𝗮𝘁 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗲𝘀 𝘁𝗵𝗲 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗼𝗳 𝗮 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗽𝗮𝗻𝗲𝗹?

Probe design is one of the fundamental factors influencing target enrichment performance. But effective design involves more than simply covering the target regions.

In our latest blog, Celemics shares how RNA probes, 2X tiling, probe modifications, and rebalancing based on actual wet-lab data are incorporated into its panel design approach.

We also discuss why panel performance should be evaluated transparently including regions that are inherently difficult to capture rather than simply excluding them from performance metrics.

30/07/2026
15/07/2026

Not every sample is ideal—and your NGS workflow shouldn‘t expect it to be.

From degraded FFPE tissue to ultra-low-amount ctDNA, challenging samples demand more than just deeper sequencing.

Discover how optimized library preparation, target enrichment, and UMI technology help generate reliable NGS data.

CancerGenomics

02/07/2026

We’re pleased to announce that Celemics will be exhibiting at the ASV 2026 Conference in Minneapolis, Minnesota!

📍 Booth #2
📅 July 28–30, 2026
📌 University of Minnesota Recreation and Wellness Center, North Gym

Visit our booth to learn more about Celemics’ NGS-based solutions for viral research, pathogen detection, target enrichment, and infectious disease research.

We look forward to connecting with researchers and industry professionals at ASV 2026!

29/06/2026

𝗜𝗳 𝗣𝗖𝗥 𝗮𝗺𝗽𝗹𝗶𝗰𝗼𝗻 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝘄𝗼𝗿𝗸𝘀, 𝘄𝗵𝘆 𝘂𝘀𝗲 𝗧𝗮𝗿𝗴𝗲𝘁 𝗖𝗮𝗽𝘁𝘂𝗿𝗲 𝗳𝗼𝗿 𝗽𝗮𝘁𝗵𝗼𝗴𝗲𝗻 𝗪𝗚𝗦? It‘s a question we occasionally hear from researchers.

PCR-based amplicon sequencing remains an excellent approach for well-characterized targets. However, real-world clinical and environmental samples are often more challenging—pathogen abundance may be low, nucleic acids may be fragmented, and new variants continue to emerge.
In these situations, sequencing performance depends not only on the sequencing platform, but also on the enrichment strategy.

In our latest blog, we explore why Target Capture-based WGS has become an increasingly important approach for pathogen genomic surveillance, particularly when working with challenging samples.

ngs

17/06/2026

𝗧𝗵𝗲 𝗿𝗲𝗮𝗹 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗶𝗻 𝗽𝗮𝘁𝗵𝗼𝗴𝗲𝗻 𝗡𝗚𝗦 𝗼𝗳𝘁𝗲𝗻 𝗯𝗲𝗴𝗶𝗻𝘀 𝗮𝗳𝘁𝗲𝗿 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴.

While generating sequencing data has become increasingly accessible, transforming FASTQ files into interpretable and actionable results still requires multiple analysis steps.

As pathogen genomics becomes more widely adopted in public health surveillance and infectious disease research, workflow standardization and accessibility are becoming just as important as sequencing performance itself.

In our latest blog, we explore the challenges that arise after sequencing and how an integrated analysis workflow can help streamline pathogen NGS data interpretation.

01/06/2026

We’re excited to exhibit at in Gothenburg!

Join Celemics at ESHG 2026 to explore our NGS-based solutions for clinical genomics, target enrichment, and precision medicine research.

We look forward to seeing you at ESHG 2026!

Address

19F~20F, Bldg. A, BYC Highcity, 131 Gasandigital 1-ro, Geumcheon-gu

08506

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+82267468067

Alerts

Be the first to know and let us send you an email when Celemics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Celemics, Inc.:

Shortcuts

  • Want your business to be the top-listed engineering company?

Share